Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77

Changing perspectives regarding late-life dementia. Nat Rev Neurol (2009) 2.04

Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing. Brain (2010) 2.04

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons. Neurology (2009) 1.78

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62

Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease. Neurology (2011) 1.60

Neuropathology of Alzheimer's disease. Mt Sinai J Med (2010) 1.57

Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA (2012) 1.40

Is AD a homogeneous nosologic entity? Yes. J Neural Transm (Vienna) (2013) 1.39

A population-based clinicopathological study in the oldest-old: the 90+ study. Curr Alzheimer Res (2012) 1.31

Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain (2011) 1.29

PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol (2015) 1.17

In vivo assessment of amyloid-β deposition in nondemented very elderly subjects. Ann Neurol (2013) 1.17

Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study. J Neuropsychiatry Clin Neurosci (2011) 1.15

Neuropathologic features associated with Alzheimer disease diagnosis: age matters. Neurology (2011) 1.15

Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. PLoS One (2009) 1.12

Neuropathologic basis of age-associated brain atrophy. JAMA Neurol (2013) 1.05

Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging (2012) 1.04

Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis (2013) 1.03

Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease. J Alzheimers Dis (2010) 1.02

Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project. Curr Alzheimer Res (2011) 1.01

Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res (2013) 0.93

Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias. Eur Arch Psychiatry Clin Neurosci (2012) 0.93

Dementia in the oldest old: a multi-factorial and growing public health issue. Alzheimers Res Ther (2013) 0.87

Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol (2014) 0.87

Cognitive decline and dementia in the oldest-old. Rambam Maimonides Med J (2012) 0.86

Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles. Curr Alzheimer Res (2011) 0.86

Dementia in the oldest old. Nat Rev Neurol (2013) 0.86

Dietary composition modulates brain mass and solubilizable Abeta levels in a mouse model of aggressive Alzheimer's amyloid pathology. Mol Neurodegener (2009) 0.85

Con: Can neuropathology really confirm the exact diagnosis? Alzheimers Res Ther (2010) 0.85

Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected]. PLoS One (2013) 0.85

Is there a neuropathology difference between mild cognitive impairment and dementia? Dialogues Clin Neurosci (2009) 0.85

Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett (2010) 0.84

Synaptic protein deficits are associated with dementia irrespective of extreme old age. Neurobiol Aging (2011) 0.83

Prevalence of health conditions and predictors of mortality in oldest old Mexican Americans and non-Hispanic whites. J Am Med Dir Assoc (2010) 0.82

Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia. Int Rev Psychiatry (2013) 0.81

A Population-based study of dementia in the oldest old: the Monzino 80-plus study. BMC Neurol (2011) 0.81

Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease. J Alzheimers Dis (2013) 0.80

A neuronal DNA damage response is detected at the earliest stages of Alzheimer's neuropathology and correlates with cognitive impairment in the Medical Research Council's Cognitive Function and Ageing Study ageing brain cohort. Neuropathol Appl Neurobiol (2015) 0.80

Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study. Acta Neuropathol Commun (2016) 0.80

CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease. Biol Psychiatry (2013) 0.80

Neural restrictive silencer factor and choline acetyltransferase expression in cerebral tissue of Alzheimer's Disease patients: A pilot study. Genet Mol Biol (2013) 0.79

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. Virchows Arch (2015) 0.78

Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol Aging (2015) 0.78

Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease. Mol Psychiatry (2016) 0.77

Quantitative neuropathological assessment to investigate cerebral multi-morbidity. Alzheimers Res Ther (2014) 0.77

Impaired mitochondrial energy metabolism as a novel risk factor for selective onset and progression of dementia in oldest-old subjects. Neuropsychiatr Dis Treat (2015) 0.77

Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta. Neurobiol Aging (2015) 0.76

The New Criteria for Alzheimer's Disease - Implications for Geriatricians. Can Geriatr J (2016) 0.75

The autopsy and the elderly patient in the hospital and the nursing home: enhancing the quality of life. Geriatrics (2008) 0.75

[Not Available]. Can Geriatr J (2016) 0.75

Preventing Alzheimer's disease by means of natural selection. J R Soc Interface (2015) 0.75

Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging (2017) 0.75

The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry (1968) 18.69

Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25

Diagnosis of Alzheimer's disease. Arch Neurol (1985) 12.77

Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging (1997) 10.81

Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol (2001) 8.88

Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging (1997) 7.54

Observations on the brains of demented old people. J Neurol Sci (1970) 6.99

National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med (2001) 4.69

Clinical dementia rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology (1997) 3.53

Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 3.45

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20

Age-specific incidence of Alzheimer's disease in a community population. JAMA (1995) 3.09

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging (2005) 2.97

Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65

Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52

The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35

Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology (1994) 2.10

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02

Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology (2001) 1.98

Frontotemporal dementia. Br J Psychiatry (2002) 1.95

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology (2006) 1.68

Unraveling the mystery of cognitive changes in old age: correlation of neuropsychological evaluation with neuropathological findings in the extreme old. Int Psychogeriatr (1998) 1.56

Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? J Neurol Sci (2007) 1.52

Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. Arch Neurol (1999) 1.50

Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease. Aging (Milano) (1996) 1.30

Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol Aging (2007) 1.28

Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience (2003) 1.22

Alzheimer's and dementia in the oldest-old: a century of challenges. Curr Alzheimer Res (2006) 1.20

The Clinical Dementia Rating scale: community-based validation of "profound' and "terminal' stages. Neurology (1996) 1.18

Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol (2006) 1.17

Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med (2002) 1.13

Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol (1995) 1.00

Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J Neuropathol Exp Neurol (1996) 1.00

Tau protein abnormalities associated with the progression of alzheimer disease type dementia. Neurobiol Aging (2005) 1.00

Stereologic analysis of hippocampal Alzheimer's disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field. Exp Neurol (2005) 0.96

Five-year mortality in relation to dementia and cognitive function in 95-year-olds. Neurology (2007) 0.92

Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases. Acta Neuropathol (1995) 0.87

Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.83

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol (2004) 6.14

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52

TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol (2010) 4.48

Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci U S A (2005) 2.76

Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44

Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. Am J Psychiatry (2008) 2.11

Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08

Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol (2007) 1.91

Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry (2009) 1.85

Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry (2006) 1.79

C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging. Neurology (2012) 1.77

A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry (2002) 1.72

Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry (2003) 1.69

Variability of familial risk of Alzheimer disease across the late life span. Arch Gen Psychiatry (2005) 1.63

The pattern of cognitive-functional decline in elderly essential tremor patients: an exploratory-comparative study with Parkinson's and Alzheimer's disease patients. J Am Med Dir Assoc (2009) 1.59

Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol Dis (2005) 1.56

Elaboration on premorbid intellectual performance in schizophrenia: premorbid intellectual decline and risk for schizophrenia. Arch Gen Psychiatry (2005) 1.55

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci (2005) 1.55

Brainstem pathology in DYT1 primary torsion dystonia. Ann Neurol (2004) 1.55

Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry (2012) 1.52

The impact of 9/11 on New York City's substance abuse treatment programs: a study of program administrators. J Addict Dis (2006) 1.52

Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics (2004) 1.44

Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol (2004) 1.41

Neuropsychological differences between late-onset and recurrent geriatric major depression. Am J Psychiatry (2005) 1.41

Abuse and neglect in childhood: relationship to personality disorder diagnoses. CNS Spectr (2003) 1.38

Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry (2002) 1.35

Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci (2002) 1.35

Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers. Ann Neurol (2010) 1.34

Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am J Geriatr Psychiatry (2008) 1.32

Maternal, not paternal, PTSD is related to increased risk for PTSD in offspring of Holocaust survivors. J Psychiatr Res (2008) 1.28

Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele. Am J Geriatr Psychiatry (2008) 1.28

Dementia resulting from traumatic brain injury: what is the pathology? Arch Neurol (2012) 1.25

Symptom domains in autism and related conditions: evidence for familiality. Am J Med Genet (2002) 1.21

Von Economo neurons in autism: a stereologic study of the frontoinsular cortex in children. Brain Res (2010) 1.20

Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J Comp Neurol (2003) 1.18

C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. Age Ageing (2009) 1.18

The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry (2003) 1.17

Changes in dendritic complexity and spine morphology in transgenic mice expressing human wild-type tau. Brain Struct Funct (2010) 1.13

Relationship between body height and dementia. Am J Geriatr Psychiatry (2005) 1.12

Comparison of parent and child reports of emotional trauma symptoms in pediatric outpatient settings. Pediatrics (2005) 1.11

Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers (2011) 1.11

Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol (2002) 1.11

Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J Alzheimers Dis (2012) 1.10

Hyperglycemia and outcome in the pediatric intensive care unit. J Pediatr (2008) 1.10

Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology (2005) 1.10

Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol Psychiatry (2006) 1.09

Autism-related routines and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12 polymorphism. Am J Med Genet B Neuropsychiatr Genet (2008) 1.08

Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia. Neurobiol Aging (2007) 1.06

Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci U S A (2014) 1.04

Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease. Brain Struct Funct (2010) 1.04

Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study. Schizophr Res (2006) 1.04

Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease. Neurobiol Aging (2007) 1.04

The neuropathological basis for depression in Parkinson's disease. Parkinsonism Relat Disord (2008) 1.03

Traumatic brain injury, shell shock, and posttraumatic stress disorder in the military--past, present, and future. J Head Trauma Rehabil (2012) 1.03

Diabetes is associated with increased rate of cognitive decline in questionably demented elderly. Dement Geriatr Cogn Disord (2010) 1.01

Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. Am J Pathol (2007) 1.01

Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. Am J Pathol (2009) 1.00

Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals. Mech Ageing Dev (2011) 1.00

Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease. J Neuropathol Exp Neurol (2003) 1.00

Familial symptom domains in monozygotic siblings with autism. Am J Med Genet B Neuropsychiatr Genet (2004) 0.98

Absolute measurement of cerebral optical coefficients, hemoglobin concentration and oxygen saturation in old and young adults with near-infrared spectroscopy. J Biomed Opt (2012) 0.97

Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr (2006) 0.96

Twenty-four hour plasma cortisol and adrenocorticotropic hormone in Gulf War veterans: relationships to posttraumatic stress disorder and health symptoms. Biol Psychiatry (2007) 0.95

The impact of a family empowerment intervention on juvenile offender heavy drinking: a latent growth model analysis. Subst Use Misuse (2002) 0.93

Peritraumatic reactions associated with the World Trade Center disaster. Am J Psychiatry (2003) 0.93

The impact of 9/11 on patients in New York City's substance abuse treatment programs. Am J Drug Alcohol Abuse (2006) 0.92

Slc25a12 disruption alters myelination and neurofilaments: a model for a hypomyelination syndrome and childhood neurodevelopmental disorders. Biol Psychiatry (2009) 0.92

Pediatric emergency department assessment of psychological trauma and posttraumatic stress. Psychiatr Serv (2003) 0.92

Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Acta Neuropathol (2006) 0.92

A phenotype for genetic studies of successful cognitive aging. Am J Med Genet B Neuropsychiatr Genet (2008) 0.92

Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br J Psychiatry (2004) 0.92

Decreased pyramidal neuron size in Brodmann areas 44 and 45 in patients with autism. Acta Neuropathol (2012) 0.91

Hippocampal and entorhinal cortex neurofibrillary tangle formation in Guamanian Chamorros free of overt neurologic dysfunction. J Neuropathol Exp Neurol (2003) 0.91

FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. PLoS One (2009) 0.91

The Mental Health, Substance Use, and Delinquency among Truant Youths in a Brief Intervention Project: A Longitudinal Study. J Emot Behav Disord (2013) 0.91

The prevalence of distress in persons with human immunodeficiency virus infection. Psychosomatics (2002) 0.91

Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica. J Alzheimers Dis (2011) 0.91

Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor. J Neurochem (2007) 0.90

Individual and community risk factors and sexually transmitted diseases among arrested youths: a two level analysis. J Behav Med (2009) 0.90

Cognitive decline in patients with dementia as a function of depression. Am J Geriatr Psychiatry (2011) 0.89